Lmp1 and Lmp2-specific CTLs following CD45 antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lmp1 and Lmp2-specific CTLs following CD45 antibody, covering 2012-05-24 to 2012-05-24. Get the full timeline:
Most recent: Clinical Trial Update: Lmp1 and Lmp2 Specific CTLs Following Cd45 Antibody for Relapsed Ebv-Positive Hodgkin's Or Non-Hodgkin's Lymphoma [Phase 1]